These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 27556959)

  • 1. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic Intracranial Venous Hypertension: Toward a Better Understanding of Venous Stenosis and the Role of Stenting in Idiopathic Intracranial Hypertension.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2023 Dec; 43(4):451-463. PubMed ID: 37410913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
    Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
    Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.
    Hendrix P; Whiting CJ; Griessenauer CJ; Bohan C; Schirmer CM; Goren O
    Neurosurg Rev; 2022 Jun; 45(3):2239-2247. PubMed ID: 35067804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior Ophthalmic Vein Flow Patterns as a Marker of Venous Sinus Stenosis and Hypertension in Idiopathic Intracranial Hypertension: A Case of Emergent Transverse Sinus Stenting as Treatment of Fulminant Idiopathic Intracranial Hypertension.
    Mugge L; Dang D; Curry B; Whiting R; Crimmins M
    World Neurosurg; 2022 May; 161():170-178. PubMed ID: 34224883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
    Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
    Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.
    Liu KC; Starke RM; Durst CR; Wang TR; Ding D; Crowley RW; Newman SA
    J Neurosurg; 2017 Nov; 127(5):1126-1133. PubMed ID: 28009240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of idiopathic intracranial hypertension in children utilizing venous sinus stenting.
    Schwarz J; Al Balushi A; Sundararajan S; Dinkin M; Oliveira C; Greenfield JP; Patsalides A
    Interv Neuroradiol; 2021 Apr; 27(2):257-265. PubMed ID: 33236688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature.
    Puffer RC; Mustafa W; Lanzino G
    J Neurointerv Surg; 2013 Sep; 5(5):483-6. PubMed ID: 22863980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of papilledema and visual improvement in patients with idiopathic intracranial hypertension after venous sinus stenting].
    Wang W; Jia Q; Fan YM; Li XD; Wang SB; Cheng L; Wang HG; Liang WL; Bian LZ; Tong XG
    Zhonghua Wai Ke Za Zhi; 2021 Dec; 59(12):1012-1017. PubMed ID: 34839617
    [No Abstract]   [Full Text] [Related]  

  • 11. Reductions in bilateral transverse sinus pressure gradients with unilateral transverse venous sinus stenting for idiopathic intracranial hypertension.
    Larson A; Rinaldo L; Chen JJ; Cutsforth-Gregory J; Theiler AR; Brinjikji W
    J Neurointerv Surg; 2021 Feb; 13(2):187-190. PubMed ID: 32482835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
    ; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
    Vosoughi AR; Margolin EA; Micieli JA
    J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous sinus stenting lowers the intracranial pressure in patients with idiopathic intracranial hypertension.
    Patsalides A; Oliveira C; Wilcox J; Brown K; Grover K; Gobin YP; Dinkin MJ
    J Neurointerv Surg; 2019 Feb; 11(2):175-178. PubMed ID: 29871989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.
    Rebolleda G; Muñoz-Negrete FJ
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5197-200. PubMed ID: 19011007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dural sinus stent placement for idiopathic intracranial hypertension.
    Kumpe DA; Bennett JL; Seinfeld J; Pelak VS; Chawla A; Tierney M
    J Neurosurg; 2012 Mar; 116(3):538-48. PubMed ID: 22149379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography.
    Smith KA; Peterson JC; Arnold PM; Camarata PJ; Whittaker TJ; Abraham MG
    Int J Neurosci; 2017 Feb; 127(2):145-153. PubMed ID: 26863329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
    ;
    Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous sinus stenting shortens the duration of medical therapy for increased intracranial pressure secondary to venous sinus stenosis.
    Shazly TA; Jadhav AP; Aghaebrahim A; Ducruet AF; Jankowitz BT; Jovin TG; Bonhomme GR
    J Neurointerv Surg; 2018 Mar; 10(3):310-314. PubMed ID: 28487359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transverse venous sinus stenting for idiopathic intracranial hypertension: Safety and feasibility.
    Koovor JM; Lopez GV; Riley K; Tejada J
    Neuroradiol J; 2018 Oct; 31(5):513-517. PubMed ID: 29882475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.